As global markets react to shifting trade policies, the Australian market is poised for a modest rise, reflecting an optimistic sentiment. In this context, penny stocks—though often considered outdated—remain a compelling area of interest for investors seeking affordable entry points into potentially high-growth sectors. While these stocks typically involve smaller or newer companies, those with strong financial health can offer intriguing opportunities for growth.
Top 10 Penny Stocks In Australia
| Name | Share Price | Market Cap | Rewards & Risks |
| Alfabs Australia (ASX:AAL) | A$0.38 | A$108.9M | ✅ 3 ⚠️ 3 View Analysis > |
| EZZ Life Science Holdings (ASX:EZZ) | A$2.15 | A$101.42M | ✅ 4 ⚠️ 3 View Analysis > |
| GTN (ASX:GTN) | A$0.605 | A$115.35M | ✅ 3 ⚠️ 2 View Analysis > |
| IVE Group (ASX:IGL) | A$2.98 | A$459.46M | ✅ 4 ⚠️ 2 View Analysis > |
| West African Resources (ASX:WAF) | A$2.30 | A$2.62B | ✅ 5 ⚠️ 1 View Analysis > |
| Southern Cross Electrical Engineering (ASX:SXE) | A$1.73 | A$457.43M | ✅ 4 ⚠️ 1 View Analysis > |
| Regal Partners (ASX:RPL) | A$2.65 | A$891M | ✅ 4 ⚠️ 2 View Analysis > |
| Sugar Terminals (NSX:SUG) | A$0.99 | A$360M | ✅ 2 ⚠️ 2 View Analysis > |
| Navigator Global Investments (ASX:NGI) | A$1.66 | A$813.53M | ✅ 5 ⚠️ 3 View Analysis > |
| CTI Logistics (ASX:CLX) | A$1.84 | A$148.2M | ✅ 4 ⚠️ 2 View Analysis > |
Click here to see the full list of 460 stocks from our ASX Penny Stocks screener.
Let's dive into some prime choices out of the screener.
Alcidion Group (ASX:ALC)
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Alcidion Group Limited develops and licenses healthcare software products across Australia, New Zealand, and the United Kingdom, with a market cap of A$147.72 million.
Operations: The company's revenue is derived from the provision of healthcare software solutions, totaling A$35.64 million.
Market Cap: A$147.72M
Alcidion Group Limited, with a market cap of A$147.72 million and revenue of A$35.64 million, is unprofitable but maintains a positive cash flow and sufficient cash runway for over three years. The company has no debt, although its short-term liabilities exceed its assets by A$1.4 million. Recent changes include the retirement of Non-Executive Director Victoria Weekes and Danny Sharp's new role as Chair of the Audit and Risk Committee. Despite losses increasing at 20.2% annually over five years, earnings are forecast to grow significantly at 106% per year according to consensus estimates.
- Jump into the full analysis health report here for a deeper understanding of Alcidion Group.
- Gain insights into Alcidion Group's future direction by reviewing our growth report.
Cogstate (ASX:CGS)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Cogstate Limited is a neuroscience technology company that focuses on creating, validating, and commercializing digital brain health assessments for academic and industry-sponsored research, with a market cap of A$295.41 million.
Operations: Cogstate generates revenue from two main segments: Healthcare (including Sport) which contributes $2.98 million, and Clinical Trials (including Precision Recruitment Tool & Research) which brings in $44.22 million.
Market Cap: A$295.41M
Cogstate Limited, with a market cap of A$295.41 million, has shown robust financial health and growth potential. The company is debt-free, with short-term assets of A$46.9 million comfortably covering both short-term and long-term liabilities. Recent earnings guidance anticipates full-year revenue between A$52 million and A$54 million, marking a 20% to 24% improvement from the previous year. Cogstate's earnings have grown by an impressive 33.3% over the past year, outpacing its five-year average growth rate of 31.9%. Despite a low return on equity at 16.6%, its high-quality earnings underscore solid operational performance in the neuroscience technology sector.
- Dive into the specifics of Cogstate here with our thorough balance sheet health report.
- Understand Cogstate's earnings outlook by examining our growth report.
GR Engineering Services (ASX:GNG)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: GR Engineering Services Limited offers engineering, procurement, and construction services to the mining and mineral processing sectors both in Australia and internationally, with a market cap of A$562.49 million.
Operations: The company's revenue is derived from two main segments: Oil and Gas, contributing A$96.61 million, and Mineral Processing, which generates A$412.30 million.
Market Cap: A$562.49M
GR Engineering Services, with a market cap of A$562.49 million, demonstrates solid financial health and growth potential in the engineering sector. The company is debt-free and its short-term assets of A$180 million exceed both short-term and long-term liabilities. Its recent earnings growth of 34.3% surpasses the industry average, highlighting robust operational performance. With an outstanding return on equity at 53%, GR Engineering's profitability has improved alongside stable weekly volatility over the past year. Despite an unstable dividend track record, its high-quality earnings and experienced management team enhance its appeal in the penny stock landscape.
- Navigate through the intricacies of GR Engineering Services with our comprehensive balance sheet health report here.
- Explore historical data to track GR Engineering Services' performance over time in our past results report.
Key Takeaways
- Dive into all 460 of the ASX Penny Stocks we have identified here.
- Looking For Alternative Opportunities? Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if GR Engineering Services might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com